| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2360366A1 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections |
| 07/20/2000 | CA2360358A1 Compositions having improved stability |
| 07/20/2000 | CA2360356A1 .beta.-phenylalanine derivatives as integrin antagonists |
| 07/20/2000 | CA2360232A1 Telomerase inhibitors |
| 07/20/2000 | CA2360227A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 07/20/2000 | CA2360060A1 Steroid derived antibiotics |
| 07/20/2000 | CA2359990A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | CA2359986A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359980A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359678A1 Use of s-triazines for treating apicomplexan parasitic infections |
| 07/20/2000 | CA2359569A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2359557A1 Process and products of purification of anhydrosugar alcohols |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359478A1 Administration of an anti-endotoxin drug by intravenous infusion |
| 07/20/2000 | CA2359474A1 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | CA2359449A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2359404A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | CA2359390A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 07/20/2000 | CA2359381A1 Medicament forms having controlled release and containing active substances which easily dissolve in water |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359349A1 A method for introducing substances into cells, and use of said method |
| 07/20/2000 | CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/20/2000 | CA2359273A1 Pharmaceutical formulations containing an opioid and an .alpha.-agonist |
| 07/20/2000 | CA2359253A1 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia |
| 07/20/2000 | CA2359244A1 .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 07/20/2000 | CA2359110A1 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358662A1 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | CA2358638A1 Composition and methods for administration of water-insoluble paclitaxel derivatives |
| 07/20/2000 | CA2357726A1 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | CA2356990A1 Composition and method for improving function of embryonic kidney transplants |
| 07/20/2000 | CA2356944A1 Compositions having improved stability |
| 07/20/2000 | CA2356934A1 Serine protease inhibitors |
| 07/20/2000 | CA2356850A1 Dry skin remedies |
| 07/20/2000 | CA2356776A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | CA2356532A1 Noninvasive vascular therapy |
| 07/20/2000 | CA2356440A1 New dialysis method |
| 07/20/2000 | CA2356290A1 Benzenic sulphonamide derivatives and their uses |
| 07/20/2000 | CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | CA2355374A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | CA2353088A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | CA2328092A1 Method of isolating mucilaginous polysaccharides and uses thereof |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | CA2323711A1 Composition for treating obesity and aesthetic treatment method |
| 07/20/2000 | CA2296224A1 Use of imidazo(1,5-a)pyrido(3,2-e)pyrazinones |
| 07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 07/19/2000 | EP1020474A1 Oligosaccharide derivatives and process for producing the same |
| 07/19/2000 | EP1020471A1 Process for producing UCN-01 |
| 07/19/2000 | EP1020470A2 Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 07/19/2000 | EP1020469A2 Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 07/19/2000 | EP1020465A1 Stereoisomeric indole compounds, process for the preparation of the same, and use thereof |
| 07/19/2000 | EP1020464A1 Paroxetine methansulfonate |
| 07/19/2000 | EP1020463A1 Paroxetine methanesulfonate |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020459A1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
| 07/19/2000 | EP1020458A1 Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same |
| 07/19/2000 | EP1020452A1 Benzimidazole derivatives |
| 07/19/2000 | EP1020439A1 Cetp activity inhibitors |
| 07/19/2000 | EP1020426A1 Amine derivatives and process for producing the same |
| 07/19/2000 | EP1020193A1 Oral preparation |
| 07/19/2000 | EP1020192A2 Composition against cellulitis |
| 07/19/2000 | EP1020191A1 Medicaments for hypolipidemic and hypoglycemic conditions |
| 07/19/2000 | EP1020190A2 Treatment of BPH with cGMP elevators |
| 07/19/2000 | EP1020189A1 Prophylactic or therapeutic agent for amnesia |
| 07/19/2000 | EP1020188A1 New use of taxoid derivatives |
| 07/19/2000 | EP1020187A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/19/2000 | EP1020186A2 Sustained release tramadol preparations with a storage stable release profile and process for their manufacture |
| 07/19/2000 | EP1020185A2 Opioid analgesics with controlled release |
| 07/19/2000 | EP1020184A1 Sustained release tablets containing bupropion hydrochloride |
| 07/19/2000 | EP1020183A2 Analgesic composition with controlled release |
| 07/19/2000 | EP1020181A1 Process for producing pellets with a pharmaceutical agent content of up to 90% w/w |
| 07/19/2000 | EP1020180A2 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 07/19/2000 | EP1019728A1 Method of activating a novel ligand regulatory pathway |
| 07/19/2000 | EP1019726A1 Prevention of sudden infant death |
| 07/19/2000 | EP1019714A2 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene |
| 07/19/2000 | EP1019533A1 Silanol enzyme inhibitors |
| 07/19/2000 | EP1019530A1 A method of treating cancer |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019499A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/19/2000 | EP1019497A1 Hammerhead ribozymes with extended cleavage rule |
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019429A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 07/19/2000 | EP1019428A2 Inverted chimeric and hybrid oligonucleotides |
| 07/19/2000 | EP1019427A1 N?6 -substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 07/19/2000 | EP1019426A1 Novel a 1? adenosine receptor agonists and antagonists |
| 07/19/2000 | EP1019425A1 Modified benzimidazole nucleosides as antiviral agents |